Complete financial analysis of Walgreens Boots Alliance, Inc. (WBA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Walgreens Boots Alliance, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Greatview Aseptic Packaging Company Limited (GRVWF) Income Statement Analysis – Financial Results
- ENENSYS Technologies SA (ALNN6.PA) Income Statement Analysis – Financial Results
- Hilton Worldwide Holdings Inc. (0J5I.L) Income Statement Analysis – Financial Results
- Wockhardt Limited (WOCKPHARMA.NS) Income Statement Analysis – Financial Results
- Severn Trent Plc (SVTRF) Income Statement Analysis – Financial Results
Walgreens Boots Alliance, Inc. (WBA)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.66B | 139.08B | 132.70B | 132.51B | 121.98B | 120.07B | 131.54B | 118.21B | 117.35B | 103.44B | 76.39B | 72.22B | 71.63B | 72.18B | 67.42B | 63.34B | 59.03B | 53.76B | 47.41B | 42.20B | 37.51B | 32.51B | 28.68B | 24.62B | 21.21B | 17.84B | 15.31B | 13.36B | 11.78B | 10.40B | 9.24B | 8.29B | 7.48B | 6.73B | 6.05B | 5.38B | 4.88B | 4.28B | 3.66B | 3.16B |
| Cost of Revenue | 121.13B | 112.01B | 104.44B | 104.44B | 95.91B | 91.92B | 100.75B | 89.05B | 87.48B | 76.59B | 54.82B | 51.10B | 51.29B | 51.69B | 48.44B | 45.72B | 42.39B | 38.52B | 34.24B | 30.41B | 27.31B | 23.71B | 21.08B | 18.05B | 15.24B | 12.77B | 10.95B | 9.52B | 8.37B | 7.35B | 6.50B | 5.85B | 5.29B | 4.74B | 4.29B | 3.78B | 3.41B | 2.95B | 2.51B | 2.16B |
| Gross Profit | 26.52B | 27.07B | 28.27B | 28.07B | 26.08B | 28.16B | 30.79B | 29.16B | 29.87B | 26.86B | 21.57B | 21.12B | 20.34B | 20.49B | 18.98B | 17.61B | 16.64B | 15.24B | 13.17B | 11.79B | 10.20B | 8.80B | 7.61B | 6.57B | 5.97B | 5.07B | 4.36B | 3.85B | 3.41B | 3.04B | 2.74B | 2.44B | 2.19B | 1.99B | 1.76B | 1.60B | 1.47B | 1.33B | 1.15B | 1.00B |
| Gross Profit Ratio | 17.96% | 19.46% | 21.30% | 21.18% | 21.38% | 23.45% | 23.41% | 24.67% | 25.46% | 25.96% | 28.23% | 29.24% | 28.40% | 28.39% | 28.15% | 27.81% | 28.19% | 28.35% | 27.78% | 27.93% | 27.19% | 27.07% | 26.52% | 26.70% | 28.16% | 28.42% | 28.46% | 28.77% | 28.96% | 29.29% | 29.66% | 29.42% | 29.29% | 29.53% | 29.13% | 29.65% | 30.18% | 31.16% | 31.54% | 31.75% |
| Research & Development | 0.00 | 371.00M | 307.00M | 284.00M | 300.00M | 260.00M | 254.00M | 245.00M | 238.00M | 178.00M | 127.00M | 105.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.62B | 24.70B | 24.13B | 23.03B | 22.30B | 22.60B | 23.97B | 23.05B | 22.83B | 21.18B | 17.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 694.00M | 775.00M | 862.00M | 772.00M | 532.00M | 582.00M | 665.00M | 571.00M | 598.00M | 491.00M | 265.00M | 286.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.11B | 25.48B | 24.99B | 23.80B | 22.84B | 23.18B | 24.64B | 23.62B | 23.43B | 21.67B | 17.69B | 17.47B | 16.88B | 16.56B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.52B | 3.84B | 3.33B | 2.97B | 2.66B | 2.39B | 2.16B | 1.93B | 1.74B | 1.58B | 1.41B | 1.28B | 1.19B | 1.07B | 914.00M | 791.70M |
| Other Expenses | 0.00 | 8.10B | 1.58B | 1.64B | 1.96B | -50.00M | -389.00M | -185.00M | 210.00M | 344.00M | -443.00M | 0.00 | 0.00 | -434.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| Operating Expenses | 40.60B | 33.95B | 26.88B | 25.73B | 25.10B | 23.39B | 24.50B | 23.68B | 23.87B | 22.19B | 17.38B | 16.98B | 16.88B | 16.13B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.75B | 4.05B | 3.52B | 3.14B | 2.81B | 2.52B | 2.28B | 2.03B | 1.83B | 1.67B | 1.48B | 1.34B | 1.25B | 1.12B | 957.80M | 826.10M |
| Cost & Expenses | 161.73B | 145.96B | 131.32B | 130.17B | 121.00B | 115.31B | 125.25B | 112.73B | 111.35B | 98.78B | 72.20B | 68.08B | 68.17B | 67.82B | 63.96B | 60.09B | 55.59B | 50.61B | 44.71B | 39.78B | 35.37B | 30.66B | 27.06B | 23.22B | 19.98B | 16.82B | 14.47B | 12.66B | 11.17B | 9.88B | 8.78B | 7.89B | 7.12B | 6.41B | 5.76B | 5.13B | 4.66B | 4.07B | 3.46B | 2.98B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.00M | 0.00 | 0.00 | 0.00 | 0.00 | 134.00M | 0.00 | 95.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 482.00M | 580.00M | 396.00M | 491.00M | 613.00M | 650.00M | 616.00M | 693.00M | 596.00M | 605.00M | 156.00M | 165.00M | 88.00M | 71.00M | 85.00M | 83.00M | 11.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.46B | 1.89B | 1.68B | 1.69B | 1.63B | 1.78B | 1.52B | 1.41B | 1.48B | 1.56B | 1.21B | 1.18B | 1.17B | 1.09B | 1.03B | 975.00M | 840.00M | 675.90M | 572.20M | 482.10M | 403.10M | 346.10M | 307.30M | 269.20M | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| EBITDA | -11.28B | 3.48B | 4.96B | 5.96B | 2.84B | 6.75B | 7.67B | 6.95B | 7.93B | 6.75B | 5.08B | 5.34B | 4.63B | 5.45B | 4.49B | 4.22B | 4.28B | 3.83B | 3.27B | 2.91B | 2.55B | 2.21B | 1.93B | 1.67B | 1.45B | 1.23B | 1.02B | 872.60M | 751.40M | 651.60M | 573.80M | 510.90M | 450.60M | 405.50M | 354.60M | 317.30M | 283.60M | 264.40M | 240.40M | 212.20M |
| EBITDA Ratio | -7.64% | -1.86% | 4.80% | 4.12% | 2.37% | 5.31% | 6.36% | 6.09% | 6.36% | 7.40% | 6.58% | 7.37% | 6.46% | 7.55% | 6.66% | 6.67% | 7.25% | 7.12% | 6.91% | 6.89% | 6.74% | 6.66% | 6.71% | 6.68% | 6.70% | 6.87% | 6.45% | 6.48% | 6.34% | 6.22% | 6.15% | 6.16% | 5.89% | 5.89% | 5.61% | 5.73% | 5.72% | 6.15% | 6.51% | 6.65% |
| Operating Income | -14.08B | -6.88B | 1.39B | 2.34B | 982.00M | 4.77B | 6.29B | 5.48B | 6.00B | 4.67B | 4.19B | 3.65B | 3.46B | 4.37B | 3.46B | 3.25B | 3.44B | 3.15B | 2.70B | 2.42B | 2.14B | 1.85B | 1.62B | 1.40B | 1.22B | 1.02B | 835.00M | 708.00M | 604.10M | 520.10M | 455.70M | 406.20M | 358.50M | 321.20M | 284.20M | 253.50M | 224.20M | 210.70M | 196.60M | 177.80M |
| Operating Income Ratio | -9.53% | -4.95% | 1.05% | 1.77% | 0.81% | 3.97% | 4.78% | 4.64% | 5.11% | 4.51% | 5.49% | 5.05% | 4.84% | 6.05% | 5.13% | 5.13% | 5.83% | 5.86% | 5.70% | 5.74% | 5.71% | 5.69% | 5.66% | 5.68% | 5.77% | 5.69% | 5.46% | 5.30% | 5.13% | 5.00% | 4.93% | 4.90% | 4.80% | 4.77% | 4.70% | 4.71% | 4.59% | 4.92% | 5.37% | 5.62% |
| Total Other Income/Expenses | -126.00M | 1.46B | 2.65B | 280.00M | -505.00M | -399.00M | -260.00M | -623.00M | -813.00M | 667.00M | -637.00M | -45.00M | -88.00M | -71.00M | -85.00M | -83.00M | -11.00M | 28.80M | 52.60M | -11.30M | 17.00M | 23.40M | 13.10M | 24.40M | 39.20M | 11.90M | 42.10M | 4.60M | 2.80M | 3.70M | 2.70M | -6.50M | -5.50M | -9.20M | -3.30M | -9.70M | -15.20M | -16.60M | -9.00M | -4.10M |
| Income Before Tax | -14.20B | -5.39B | 4.04B | 2.62B | 477.00M | 4.37B | 6.03B | 4.86B | 5.19B | 5.34B | 3.56B | 4.05B | 3.38B | 4.29B | 3.37B | 3.16B | 3.43B | 3.19B | 2.75B | 2.46B | 2.18B | 1.89B | 1.64B | 1.42B | 1.26B | 1.03B | 877.00M | 712.00M | 606.90M | 523.80M | 458.40M | 399.70M | 353.00M | 312.00M | 280.90M | 243.80M | 209.00M | 194.10M | 187.60M | 173.70M |
| Income Before Tax Ratio | -9.62% | -3.87% | 3.04% | 1.98% | 0.39% | 3.64% | 4.58% | 4.11% | 4.42% | 5.16% | 4.66% | 5.60% | 4.71% | 5.95% | 5.00% | 5.00% | 5.81% | 5.93% | 5.81% | 5.82% | 5.80% | 5.81% | 5.71% | 5.78% | 5.96% | 5.76% | 5.73% | 5.33% | 5.15% | 5.04% | 4.96% | 4.82% | 4.72% | 4.63% | 4.64% | 4.53% | 4.28% | 4.53% | 5.12% | 5.49% |
| Income Tax Expense | 1.25B | 1.86B | 30.00M | 667.00M | 339.00M | 577.00M | 998.00M | 760.00M | 997.00M | 1.06B | 1.53B | 1.50B | 1.25B | 1.58B | 1.28B | 1.16B | 1.27B | 1.15B | 1.00B | 896.10M | 816.10M | 713.00M | 618.10M | 537.10M | 486.40M | 403.20M | 340.00M | 276.00M | 235.20M | 203.00M | 176.50M | 154.40M | 132.40M | 117.00M | 106.30M | 89.60M | 79.90M | 90.60M | 84.50M | 79.50M |
| Net Income | -8.64B | -3.08B | 4.34B | 2.54B | 456.00M | 3.98B | 5.02B | 4.08B | 4.17B | 4.22B | 1.93B | 2.55B | 2.13B | 2.71B | 2.09B | 2.01B | 2.16B | 2.04B | 1.75B | 1.56B | 1.36B | 1.18B | 1.02B | 885.60M | 776.90M | 624.10M | 511.00M | 436.00M | 371.70M | 320.80M | 281.90M | 221.70M | 220.60M | 195.00M | 174.60M | 154.20M | 129.10M | 103.50M | 103.10M | 94.20M |
| Net Income Ratio | -5.85% | -2.21% | 3.27% | 1.92% | 0.37% | 3.32% | 3.82% | 3.45% | 3.56% | 4.08% | 2.53% | 3.53% | 2.97% | 3.76% | 3.10% | 3.17% | 3.65% | 3.80% | 3.69% | 3.70% | 3.63% | 3.62% | 3.55% | 3.60% | 3.66% | 3.50% | 3.34% | 3.26% | 3.16% | 3.09% | 3.05% | 2.67% | 2.95% | 2.90% | 2.89% | 2.87% | 2.64% | 2.42% | 2.82% | 2.98% |
| EPS | -10.01 | -3.57 | 5.02 | 2.31 | 0.20 | 4.14 | 5.07 | 3.80 | 3.85 | 4.05 | 2.03 | 2.69 | 2.43 | 2.97 | 2.13 | 2.03 | 2.18 | 2.04 | 1.73 | 1.53 | 1.32 | 1.14 | 1.00 | 0.87 | 0.77 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -10.01 | -3.57 | 5.01 | 2.30 | 0.20 | 4.13 | 5.05 | 3.78 | 3.82 | 4.00 | 2.00 | 2.67 | 2.42 | 2.94 | 2.12 | 2.02 | 2.17 | 2.03 | 1.72 | 1.52 | 1.31 | 1.13 | 0.99 | 0.86 | 0.76 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 863.10M | 863.20M | 864.40M | 864.80M | 879.40M | 921.50M | 991.00M | 1.07B | 1.08B | 1.04B | 953.10M | 946.00M | 874.70M | 915.10M | 981.70M | 990.00M | 990.61M | 998.63M | 1.01B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.01B | 1.00B | 1.98B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
| Weighted Avg Shares Out (Dil) | 863.10M | 863.20M | 865.90M | 866.40M | 880.30M | 923.50M | 995.00M | 1.08B | 1.09B | 1.05B | 965.20M | 955.20M | 880.10M | 924.50M | 987.90M | 991.30M | 995.54M | 1.01B | 1.02B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.02B | 1.01B | 2.01B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
Walgreens names Optum's Jason Stenta as chief commercial officer
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday.
Walgreens: No Catalysts To Drive A Turnaround
In addition to weak consumer behavior and retail pharmacy industry headwinds, app downloads data suggests Walgreens is lagging vs. competition such as CVS. WBA has missed on margin expectations for multiple quarters now, and these pressures are expected to continue...
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Walgreens Boots Alliance, Inc. (WBA)
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 18, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Walgreens Boots Alliance, Inc. (“Walgreens” or the...
Walgreens Announces New Student Loan 401(k) Match Program
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the leading independent retail pharmacy and healthcare provider, is announcing today the launch of the Walgreens Student Loan 401(k) Match Program. This new benefit, available beginning in January 2025, will allow team members to qualify for company...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Walgreens Boots Alliance, Inc. (WBA) Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (“Walgreens” or the...
2 Top Picks With Contrarian Potential as Q4 Looms
Subscribers to Chart of the Week received this commentary on Sunday, September 29.
Dividends Don't (Usually) Lie
September 30, 2024 (Maple Hill Syndicate) – Geraldine Weiss, who died two years ago at age 96, was a successful investment newsletter writer at a time when few women were prominent in finance. She wrote a book called Dividends Don't...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Walgreens Boots Alliance, Inc. (WBA) Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Walgreens Boots Alliance, Inc. (WBA) Investors.
Walgreens: So Bad It's Good Heading Into Earnings (Rating Upgrade)
Walgreens (WBA) faces a challenging outlook with weak profit forecasts and negative EPS revisions, but technical signals suggest a potential upside, prompting a buy rating. Despite bearish trends and a recent dividend cut, WBA's valuation metrics are extremely low, making...
Source: https://incomestatements.info
Category: Stock Reports